1. Introduction {#s0005}
===============

Progressive supranuclear palsy (PSP) is a tauopathy characterized by a complex and heterogenic clinical presentation ([@bb0010]). In classical form (Richardson\'s syndrome), gait difficulty and falls are the most common initial manifestation and, as the disease progresses, other neurologic features appear, including dysphagia and dysarthria, eye movement abnormalities, parkinsonism and frontal cognitive dysfunction ([@bb0040]).

Structural radiological features in PSP include atrophy of the midbrain, the middle and superior cerebellar peduncles ([@bb0230]; [@bb0235]) and of deep gray matter structures, including the caudate, thalamus, putamen and hippocampus, and brainstem ([@bb0195]; [@bb0245]; [@bb0080]). Additionally, frontal cortical atrophy has also been consistently found ([@bb0060]; [@bb0065]; [@bb0045]). In line with the aforementioned, it has been hypothesized that clinical manifestations in PSP might result from the degeneration of deep gray matter structures, consequently disrupting cortico-subcortical brain circuits ([@bb0075]; [@bb0185]; [@bb0070]).

Diffusion-weighted MRI (DWI) is a widely used technique to characterize the integrity of white matter (WM) tracts. In PSP, WM abnormalities have been predominantly found in the superior longitudinal fasciculus, corpus callosum and superior and middle cerebellar peduncles ([@bb0220]; [@bb0335], [@bb0340]; [@bb0300], [@bb0305]; [@bb0005]; [@bb0345]), along with deep gray matter structure involvement ([@bb0220]; [@bb0325]; [@bb0335]; [@bb0315]; [@bb0305]). Some studies also reported the contribution of WM alterations to clinical disease severity as well as performance in cognitive tests ([@bb0005]; [@bb0305]; [@bb0325]; [@bb0340]; [@bb0345]).

Tractography is an advanced DWI modality that allows reconstructing white matter fiber pathways of the brain and quantifying the local fiber density. The combination of tractography with graph theory has led to promising applications, as it can be used to describe the reconstructed structural brain connectome -- i.e., a comprehensive description of the structural connections between brain regions ([@bb0175]) -- as a complex network. This allows describing brain network regarding characteristics such as integration and segregation using global and local graph theory metrics ([@bb0050]; [@bb0240]). These summary metrics, in turn, allow explaining functionalities of the brain that are not attributable to individual brain regions but rather emerge from the network as a whole ([@bb0320]).

As far as we know, there is not published work in terms of characterizing PSP connectivity patterns by means of tractography and graph theory. In the present study, we reconstructed the structural connectome to detect the pathways of degeneration in PSP compared with healthy controls and their correlation with clinical features. Our hypothesis is that structural connectivity between cortical and deep gray matter structures is predominantly affected in PSP and that it correlates with characteristic clinical features of the disease. Furthermore, we assessed the potential discriminant ability of structural connectivity. We hypothesize that the rich information derived from the structural connectome has potential for distinguishing PSP patients from healthy controls with high accuracy. This will need to be further validated in larger cohorts encompassing the different PSP phenotypes.

2. Methods {#s0010}
==========

2.1. Participants {#s0015}
-----------------

Twenty-three probable PSP patients were recruited from the Parkinson\'s Disease and Movement Disorders Unit, Hospital Clínic de Barcelona. The inclusion criterion for PSP patients was the fulfillment of the NINDS-SPSP diagnostic criteria ([@bb0180]). The MDS PSP criteria ([@bb0150]) were retrospectively applied confirming that all patients also fulfilled them. The phenotype of each patient was also identified: 17 PSP presenting Richardson\'s syndrome (PSP-RS), 4 PSP with progressive gait freezing (PSP-PGF), 1 PSP resembling idiopathic Parkinson\'s disease (PSP-p) and 1 PSP presenting corticobasal syndrome (PSP-CBS). Twenty healthy controls (HC) matched by age, gender and years of education to PSP patients were recruited from patients\' spouses or friends who volunteered to participate in the study and from the Institut de l\'Envelliment, Universitat Autònoma de Barcelona.

Exclusion criteria consisted of: \[1\] pathological MRI findings other than mild white matter (WM) hyperintensities or suggestive of alternative diagnoses in patients, \[2\] MRI movement artifacts, \[3\] significant neurological, systemic or psychiatric comorbidity and \[4\] Mini-Mental State Examination scores \<25 or dementia in healthy participants.

Two PSP patients were excluded for excessive movement during the MR scan. One PSP patient was excluded for MR artifacts and another patient for a brain lesion in the right hemisphere. The final sample therefore consisted of 20 HC and 19 PSP patients (15 PSP-RS, 2 PSP-PGF, 1 PSP-p and 1 PSP-CBS). Sociodemographic and clinical characteristics of the groups are shown in [Table 1](#t0005){ref-type="table"}. Concretely, from the 4 non PSP-RS patients, 2 started as an atypical phenotype (PSP-p and PSP-PGF) but progressed to a more richardsonian phenotype at follow-up. Given that most patients were PSP-RS, differences between phenotypes could not be considered in the main analyses. However, complementarily, we performed additional connectivity and classification analyses considering only PSP patients with Richardson\'s phenotype.Table 1Sociodemographic and clinical characteristics by group.Table 1**HC (n** **=** **20)PSP (n** **=** **19)Stat/ pAge**73.65 (5.7)74.79 (7.4)T = 0.543/p = .910**Years of education**9.9 (3.7)7.4 (4.3)T = 1.648/p = .120**Sex (male/female)**10/1012/7χ^2^ = 0.686/p = .408**MMSE**29.05 (1.1)23.19 (4.67)T = 5.437/p \< .001[⁎](#tf0005){ref-type="table-fn"}**Years of evolution (yrs.)**--4.16 (2.03)--**H&Y (1:2:3:4:5)**--0:1:8:5:5--**PSPRS**--37.42 (10.08)--**FAB**[⁎⁎](#tf0010){ref-type="table-fn"}--10.29 (2.67)--[^1][^2][^3]

Motor disease severity in PSP patients was evaluated using the Hoehn and Yahr (H&Y) and the PSP Rating Scale (PSPRS) ([@bb0145]¸ [@bb0120]) and executive dysfunction was assessed with the Frontal Assessment Battery (FAB) ([@bb0090]). The study was approved by the Ethics Committee of the University of Barcelona and the Hospital Clinic (IRB00003099 and HCB/2015/0798, respectively). All participants provided written informed consent to participate after full explanation of the procedures involved.

2.2. MRI acquisition {#s0020}
--------------------

MRI data were acquired with a 3 T scanner (MAGNETOM Trio, Siemens, Germany). The scanning protocol included high-resolution 3-dimensional T1-weighted images acquired in the sagittal plane (TR = 2300 ms, TE = 2.98 ms, TI = 900 ms, 240 slices, FOV = 256 mm; 1 mm isotropic voxel), two sets of single band spin-echo diffusion weighted images in the axial plane with opposite (anterior-posterior and posterior-anterior) phase encoding directions (TR = 7700 ms, TE = 89 ms, FOV = 244 mm; 2 mm isotropic voxel; number of directions = 30, b-value = 1000 s/mm^2^, b~0~ value = 0 s/mm^2^) and a T2-weighted axial FLAIR sequence (TR = 9000 ms, TE = 96 ms).

2.3. MRI preprocessing {#s0025}
----------------------

Structural MRI preprocessing was performed using the automated FreeSurfer pipeline (version 5.1; available at: <https://surfer.nmr.mgh.harvard.edu/>). Independent steps were performed: removal of non-brain tissue, automated Talairach transformation, intensity normalization ([@bb0270]), tessellation of the gray matter/white matter boundary, automated topology correction ([@bb0260]), and accurate surface deformation to optimally place the gray matter/white matter and gray matter/cerebrospinal fluid boundaries ([@bb0105]). The output of each step was visually inspected to guarantee correct and accurate preprocessing. The cerebral cortex was parcellated into gyral and sulcal structures allowing the calculation of surface area measures and deep gray matter volumes were obtained from the automated FreeSurfer segmentation step ([@bb0095]; [@bb0265]; [@bb0105]).

DWI images were preprocessed with FSL (version 5.08, available at: <https://fsl.fmrib.ox.ac.uk/fsl>), concretely using the FDT (FMRIB\'s Diffusion Toolbox), a toolbox that includes tools for data processing, local diffusion modelling and tractography ([@bb0160]). Visual inspection was initially performed to identify motion-related and intensity artifacts in the DWI images. The preprocessing steps included brain extraction using BET, susceptibility-induced distortion correction using topup, and eddy-current distortion and subject motion correction with eddy. After preprocessing, images were thoroughly inspected to guarantee their quality.

2.4. Regions of interest {#s0030}
------------------------

Sixty-eight cortical regions and 18 deep gray matter (DGM) structures derived from the Desikan-Killiany Atlas ([@bb0085]) and the automated FreeSurfer segmentation atlas ([@bb0095]; [@bb0265]; [@bb0105]) were selected as regions of interest (ROIs). Supplementary Tables 1A and 1B show the list of cortical and deep gray matter ROIs, respectively. Additionally, the volumetric information of each subcortical ROI was extracted, which is often used as an atrophy marker.

In order to use these ROIs as seeds for the tractography analysis, they were linearly registered from native structural space to native diffusion space with FSL\'s Flirt ([@bb0165]; [@bb0170]). To ensure that ROI masks did not overlap with each other after registration due to resample blur, each voxel was uniquely assigned to the mask for which it had the highest value, i.e., to which it had the highest probability of membership.

2.5. Tract-based spatial statistics {#s0035}
-----------------------------------

Voxel-wise statistical analysis of FA was carried out using TBSS (Tract-Based Spatial Statistics)([@bb0280]). All subjects\' FA data were aligned into a common space and then a mean FA image was calculated and thinned to generate a mean FA skeleton, representing the centers of all white matter tracts common to the group. Each subject\'s FA maps was then projected onto this skeleton and the resulting FA skeleton images were fed into a general lineal model. The same steps were employed to obtain the MD maps.

2.6. Brain network computation {#s0040}
------------------------------

The probability distribution of fiber directions in each voxel was calculated with Bedpostx ([@bb0030]). Bedpostx runs Markov Chain Monte Carlo sampling to build up distributions on diffusion parameters at each voxel. Probtrackx ([@bb0030]) was used to estimate probabilistic connectivity between seeds, as it repeatedly samples from the voxel-wise principal diffusion direction probability distribution calculated in Bedpostx, creating a new streamline at each iteration ([@bb0365]). Five-thousand samples were generated for each seed mask, building a distribution on the likely tract location and path. A reconstructed streamline, or "fiber", was considered to connect two ROIs if it intersected both. The number of reconstructed streamlines (NOS) between each pair of ROIs was taken as the strength of structural connectivity between these regions. This process was repeated for all cortical and deep gray matter ROI pairs, to compute an 86 × 86 connectivity matrix. To reduce the risk of false-positive connections, streamlines intersecting fewer than two regions were ignored, and only connections between pairs of regions that were detected in at least 50% of the individuals were considered ([@bb0360]).

2.7. Characterization of structural connectivity {#s0045}
------------------------------------------------

In order to test for intergroup differences in interregional NOS between PSP and HC, we used TFNBS ([@bb0020]), which performs statistical inference on brain graphs. This approach combines network-based statistics ([@bb0355]), frequently used for statistical analysis of brain graphs, and threshold-free cluster enhancement, a common method in voxel-wise statistical inference ([@bb0275]). One of the main characteristics of TFNBS is that it allows generating edge-wise significance values that can be used to select relevant connectivity features. Control of the false discovery rate to 5% (FDR) was used to correct for multiple comparisons.

2.8. Graph theory computation {#s0050}
-----------------------------

The analysis of structural connectivity was complemented with topological information derived from graph theory, allowing a description of global (whole-brain) and local (nodal) properties of the network ([@bb0050]; [@bb0240]). Our network consisted of 86 nodes (cortical and deep gray matter ROIs) connected to each other by a set of edges - i.e., the number of streamlines between them. The Brain Connectivity Toolbox (BCT) was used to extract the topological parameters, including global and local clustering coefficient, global and local node degree, small worldness, path length, local efficiency and betweenness centrality (See [@bb0240] for detailed definitions and calculations of the graph metrics included in this work).

2.9. Basic statistical analyses and clinical correlates {#s0055}
-------------------------------------------------------

Intergroup comparisons of demographic, clinical, volumetric and connectivity variables were performed with the general linear model using in-house MATLAB scripts. Statistical significance was established through the Monte Carlo simulations with 10,000 permutations. Two-tailed p-values were calculated as the proportion of values in the null distribution more extreme than those observed in the actual model. FDR was then used to control for multiple comparisons. Given that the number of streamlines have a wide distribution depending on the tracts, Z-scores were calculated. Spearman correlations between clinical and imaging variables were evaluated using SPSS-24 (2016; Armonk, NY: IBM Corp.).

2.10. Classification procedure {#s0060}
------------------------------

Beyond testing for intergroup differences in structural connectivity, we were interested in assessing the usefulness of these connectivity measures in discriminating between PSP patients and HC using a supervised learning algorithm.

In order to select the most important features in an unbiased fashion, a mixed feature selection method was used for dimensionality reduction. A first set of features was selected with an intergroup comparison with TFNBS; i.e., connections whose p values were smaller than the significance threshold (0.05) were kept. Then, a based recursive feature elimination (RFE) method was adopted to select the optimal features to be introduced into the classifier. For the classification procedure, we used a logistic regression (LR) with L2 regularization, performed with the LR function from scikit-learn (<http://scikit-learn.org>), implemented in Python. LR parameters were optimized by cross-validated grid-search over a parameter grid. In order to avoid circularity in the classification, both feature selection and classification were implemented within a leave-one-out cross-validation (LOOCV). LOOCV takes one subject for testing whereas the remaining N-1 subjects are used for training the feature selection and classification algorithm. This method prevents overfitting, enhances the generalization power of the classifier, and returns an almost unbiased estimate of the probability of test error of the classification as the test subject is not included when selecting significant features or defining parameters in any training step ([@bb0200]).

To evaluate the performance of the classification procedure, we calculated its accuracy (number of subjects correctly classified as PSP patients or HC divided by total number of subjects), sensitivity (number of PSP patients correctly classified divided by the total number of PSP patients), and specificity (number of HC correctly classified divided by the total number of HC).

3. Results {#s0065}
==========

3.1. Subjects {#s0070}
-------------

[Table 1](#t0005){ref-type="table"} shows the sociodemographic and clinical characteristics of the groups. No significant intergroup differences were observed for age, gender and years of education (p = 0.910, p = 0.408 and p = 0.120, respectively). A significant effect was found between groups in MMSE scores (p \< 0.001).

3.2. Structural connectivity analysis {#s0075}
-------------------------------------

[Fig. 1](#f0005){ref-type="fig"} shows the 41 connections with significantly different number of streamlines (NOS) between groups (all p \< 0.05, FDR corrected). To test whether these edges displayed a predominant intra/inter-regional distribution or whether they were homogeneously distributed across the brain, we labeled them according to the regions connected (frontal, temporal, cingulate, parietal, occipital and deep gray matter (DGM) structures; see Supplementary Tables 2 and 3). From the 41 connections, 10 (24.4%) were found to be cortico-cortical tracts, 28 (68.3%) were cortico-DGM tracts and three (7.3%) DGM-DGM tracts (see [Fig. 2](#f0010){ref-type="fig"} for further details). Concretely, fronto-DGM connections were predominantly reduced in PSP compared with healthy controls. No connections showed significantly higher NOS in PSP patients compared with HC.Fig. 1Schematic representation of the 41 structural connections with reduced structural connectivity strength in progressive supranuclear palsy patients compared with healthy controls using threshold-free network based statistics.A. Connectivity differences between groups in cortico-cortical tracts (p \< 0.05, FDR corrected). B. Connectivity differences between groups in cortico-deep gray matter tracts (p \< 0.05, FDR corrected). C. Connectivity differences between groups in deep gray matter-deep gray matter tracts (p \< 0.05, FDR corrected). Connectivity figures were drawn using Surf Ice ([www.nitrc.org](http://www.nitrc.org){#ir0005}).Fig. 1Fig. 2Comparison of mean connectivity between progressive supranuclear palsy patients and healthy controls.Plots illustrate the distribution of the measures of average number of streamlines (NOS) between cortical and deep gray matter connections derived from the 41 significantly reduced tracts found in PSP patients using threshold-free network based statistics (TFNBS). NOS values were Z-transformed to allow better comparability. Significance of intergroup analyses (p \< 0.05, FDR corrected) are shown. HC: healthy controls; PSP: Progressive Supranuclear Palsy group; DGM: deep gray matter structures.Fig. 2

3.3. Network graph metrics {#s0080}
--------------------------

As shown in [Table 2](#t0010){ref-type="table"} and [Fig. 3](#f0015){ref-type="fig"}, no group effect was found in global graph parameters when considering the whole-brain network.Table 2AWhole-brain global graph measures by group.Table 2A**HC (n** **=** **20)PSP (n** **=** **19)Stat/ pModularity**0.5197 (0.013)0.5205 (0.158)T = 0.17697/p = .8536**Clustering coefficient**1.4638 (0.103)1.5223 (0.122)T = 1.62437/p = .2020**Nodal degree**68.295 (2.367)66.668 (2.960)T = 1.09038/p = .2025**Small Worldness**1.301 (0.083)1.3446 (0.10)T = 1.48381/p = .2025**Path Length**1.1247 (0.016)1.1318 (0.015)T = 1.39841/p = .2025[^4]Fig. 3Comparison of whole-brain global graph metrics between progressive supranuclear palsy patients and healthy controls.Plots illustrate the distribution of the nodal degree, clustering coefficient, path length, small worldness and modularity in the whole-brain network between groups. Significance of intergroup analyses (p \< 0.05, FDR corrected) are shown. HC: healthy controls; PSP: progressive supranuclear palsy group.Fig. 3

At the node-level ([Table 2](#t0015){ref-type="table"}), reduced nodal degree was observed in PSP patients compared with healthy controls in the bilateral hippocampus, the right frontal pole, and the right pars opercularis and left pars triangularis of the inferior frontal gyrus. For the sake of simplicity, given that many ROIs are considered, we only presented the regions and metrics found significant in local graph metrics.Table 2BSignificant whole-brain local graph measures by group.Table 2B**HC (n** **=** **20)PSP (n** **=** **19)Stat/ pLocal nodal degree***Left Pars Triangularis*68.15 (3.631)62.89 (6.35)*T* = 3.193/p = .0378[⁎](#tf0015){ref-type="table-fn"}*Right Pars Opercularis*55.7 (3.31)48.74 (6.682)T = 4.156/p = .0086[⁎](#tf0015){ref-type="table-fn"}*Right Frontal pole*53.25 (2.845)45.26 (7.385)T = 4.500/p = .0115[⁎](#tf0015){ref-type="table-fn"}*Left Hippocampus*81.05 (2.064)76.63 (4.153)T = 4.241/p = .0086[⁎](#tf0015){ref-type="table-fn"}*Right Hippocampus*79.65 (1.496)76.16 (5.315)T = 2.825/p = .0378[⁎](#tf0015){ref-type="table-fn"}[^5][^6]

Given the predominant reduced NOS in frontal and DGM connections previously found, we decided to complementarily study the fronto-DGM network. In this subnetwork, PSP patients showed a reduced global degree (GD) and an increase in global clustering (GC) and small worldness (SW) ([Table 3](#t0020){ref-type="table"}, [Fig. 4](#f0020){ref-type="fig"}). Locally, reduced nodal degree was found in the bilateral hippocampus, the amygdala, the pallidum, the putamen, the nucleus accumbens, the thalamus, the ventral diencephalon and the cerebellum in the right hemisphere, and in cortical areas including the pars opercularis and pars triangularis of the inferior frontal gyrus, the frontal pole, the right precentral gyrus and the left rostral middle frontal gyrus ([Table 3](#t0025){ref-type="table"}). Additionally, the other subnetworks -- temporal-DGM, parietal-DGM and occipital-DGM -- were also evaluated, showing no significant intergroup effect (see Supplementary tables 4).Table 3AGlobal graph measures in the fronto-DGM network by group.Table 3A**HC (n** **=** **20)PSP (n** **=** **19)Stat/ pModularity**0.4826 (0.021)0.481 (0.025)T = 0.23688/p = .8116**Clustering coefficient**1.608 (0.045)1.210 (0.072)T = 2.57015/p = .014[⁎](#tf0020){ref-type="table-fn"}**Nodal degree**33.862 (0.793)32.750 (1.186)T = 3.45983/p = .005[⁎](#tf0020){ref-type="table-fn"}**Small Worldness**1.087 (0.037)1.129 (0.059)T = 2.68864/p = .014[⁎](#tf0020){ref-type="table-fn"}**Path Length**1.068 (0.017)1.0718 (0.023)T = 0.585108/p = .69725[^7][^8]Fig. 4Comparison of global graph metrics between progressive supranuclear palsy patients and healthy controls in the fronto-deep gray matter subnetwork.Fig. 4Table 3BSignificant local graph measures in the fronto-DGM network by group.Table 3B**HC (n** **=** **20)PSP (n** **=** **19)Stat/ pLocal nodal degree***Left Frontal Pole*26.75 (0.91)25.26 (2.684)T = 2.341/p = .0337[⁎](#tf0025){ref-type="table-fn"}*Right Frontal Pole*27.2 (0.834)25.79 (1.584)T = 3.506/p = .0080[⁎](#tf0025){ref-type="table-fn"}*Left Pars Opercularis*29.75 (1.943)27.21 (2.226)T = 3.801/p = .0080[⁎](#tf0025){ref-type="table-fn"}*Right Pars Opercularis*28.6 (1.536)25.84 (3.354)T = 3.330/p = .0060[⁎](#tf0025){ref-type="table-fn"}*Left Pars Triangularis*34.15 (1.694)31.37 (3.32)T = 3.321/p = .0160[⁎](#tf0025){ref-type="table-fn"}*Right Pars Triangularis*35 (1.892)32.37 (3.499)T = 2.942/p = .0234[⁎](#tf0025){ref-type="table-fn"}*Left Rostral Middle Frontal*36.75 (1.743)34.16 (3.219)T = 3.149/p = .0160[⁎](#tf0025){ref-type="table-fn"}*Right Precentral*29.9 (1.119)28.16 (1.642)T = 3.889/p = .0060[⁎](#tf0025){ref-type="table-fn"}*Left Hippocampus*36.05 (1.05)33.37 (2.833)T = 3.959/p = .0060[⁎](#tf0025){ref-type="table-fn"}*Right Hippocampus*35.65 (0.671)33.47 (2.435)T = 3.849/p = .0060[⁎](#tf0025){ref-type="table-fn"}*Right Amygdala*32.75 (1.446)30.84 (2.387)T = 3.037/p = .0142[⁎](#tf0025){ref-type="table-fn"}*Right Pallidum*38.85 (0.366)38.26 (1.147)T = 2.175/p = .0395[⁎](#tf0025){ref-type="table-fn"}*Right Putamen*38.95 (0.224)38.63 (0.496)T = 2.609/p = .0357[⁎](#tf0025){ref-type="table-fn"}*Right Nucleus Accumbens*27.95 (1.05)26.63 (1.892)T = 2.709/p = .0234[⁎](#tf0025){ref-type="table-fn"}*Right VentralDC*39 (0)38.63 (0.684)T = 2.411/p = .0090[⁎](#tf0025){ref-type="table-fn"}*Right Cerebellum*35.95 (0.887)33.79 (2.72)T = 3.371/p = .0090[⁎](#tf0025){ref-type="table-fn"}[^9][^10]

Plots illustrate the distribution of the nodal degree, clustering coefficient, path length, small worldness and modularity in the fronto-deep gray matter subnetwork between groups. Significance of intergroup analyses (p \< 0.05, FDR corrected) are shown. HC: healthy controls; PSP: progressive supranuclear palsy group.

3.4. TBSS analysis {#s0085}
------------------

TBSS showed abnormal values of FA and MD in PSP patients compared with HC. Concretely, reduced FA was predominantly detected in the corpus callosum, cerebellar peduncles, bilateral anterior and superior corona radiata, bilateral superior longitudinal fasciculus and bilateral posterior thalamic radiation (Supplementary fig. 1A). Complementary, increased MD was found in the corpus callosum, fornix, bilateral anterior and superior corona radiata and bilateral posterior thalamic radiation (Supplementary fig. 1B). No regions showed decreased FA or increased MD in HC compared with PSP patients.

3.5. Correlation analyses {#s0090}
-------------------------

As described above, decreased structural connectivity was found in PSP patients compared with healthy controls. To assess the clinical relevance of this finding, significant results were then correlated with frontal assessment battery (FAB) scores and the PSP Rating scale (PSPRS) in the PSP group.

The mean NOS of the 41 significant connections identified through TFNBS negatively correlated with the PSPRS scale (r = −0.685, *p* = 0.001). We then separated the mean NOS in cortico-cortical tracts, cortico-DGM tracts and DGM-DGM tracts to assess the presence of specific effects in interregional connections. The correlation between structural connectivity and PSPRS scale was found in cortico-DGM tracts and DGM-DGM tracts (respectively, r = −0.626, p = 0.002 and *r* = −0.557, p = 0.007). Mean NOS in DGM-DGM tracts significantly correlated with years of evolution (r = −0.433, p = 0.032). The correlation between DGM-DGM NOS and PSPRS scale remained significant when including years of evolution as a covariate (r = −0.498, p = 0.018). As the strongest effects seemed to be predominantly driven by cortico-DGM tracts and PSP is known to cause frontal lobe atrophy, we then focused on fronto-DGM tracts. In this case, we found a correlation between these tracts and both the PSPRS scale and FAB scores (r = −0.546, p = 0.008 and r = 0.543, p = 0.022, respectively). A summary of these results can be found in [Fig. 5](#f0025){ref-type="fig"}. Additionally, clinical parameters were also correlated with whole-brain and fronto-DGM graph metrics, but no significant results were observed.Fig. 5Relationship between structural connectivity and clinical features in progressive supranuclear palsy patients.A. Significant correlation between the mean NOS Z-score from the 41 reduced connections in PSP patients and the PSPRS scale. B. Significant correlation between the mean NOS Z-score from the cortico-DGM (left) and the DGM-DGM (right) reduced connections in PSP patients and the PSPRS scale. C. B. Significant correlation between the mean NOS Z-score from the fronto-DGM reduced connections in PSP patients and the PSPRS (left) and FAB (right) scales. NOS: number of streamlines; PSP: progressive supranuclear palsy group; DGM: deep gray matter structures.Fig. 5

3.6. DGM volume analysis {#s0095}
------------------------

Volume reductions were found in eight DGM structures, including the bilateral putamen, pallidum, thalamus, nucleus accumbens, ventral diencephalon, cerebellum and brainstem (Supplementary table 5). Furthermore, significant correlation results were detected between PSPRS and brainstem (r = −0.67 and p = .001) and right ventral diencephalon (r = −0.56, p = .008) volumes, and between FAB and bilateral hippocampus (r = 0.56, p = .023; r = 0.62, p = .012) and left nucleus accumbens (r = 0.87, p \< .001) volumes.

3.7. Classification procedure results {#s0100}
-------------------------------------

The LR classification algorithm correctly predicted overall group membership with an accuracy of 82.23%, with 94.74% sensitivity and 70% specificity. As the leave-one-out cross-validation (LOOCV) scheme was used, the features selected in each iteration could differ slightly. The 41 structural connections that showed significant group effects when using the whole sample were obtained in \>85% of the iterations. Therefore, these connections seem to be stable in the feature selection procedure. Additionally, considering PSP subtypes, the only patient wrongly classified exhibited mixed PSP-PGF/PSP-RS characteristics.

3.8. PSP-RS subtype results {#s0105}
---------------------------

Results, shown as Supplementary data, revealed predominance of cortico-DGM reductions in PSP-RS patients, correlating with PSPRS scores, and reductions of global degree in the fronto-DGM subnetwork. Furthermore, the classification procedure achieved an overall accuracy of 85%, with 100% sensitivity and 75% specificity.

4. Discussion {#s0110}
=============

In this work, reduced structural connectivity was observed in PSP patients compared with HC. Concretely, reductions were predominantly detected in tracts linking frontal lobe regions and DGM structures, correlating with clinical scales of PSP. Furthermore, we found evidence that measures of structural connectivity might be useful to differentiate between PSP patients and HC with satisfactory accuracy.

Diffusion tensor imaging has been widely used to explore diffusion changes in PSP. When evaluating the integrity of white matter tracts, previous studies have measured different diffusion tensor-derived parameters, such as fractional anisotropy (FA) and mean diffusivity (MD), in specific regions of interest, or have performed whole-brain analyses with tract based statistics (TBSS). Diffusion abnormalities were predominantly reported in white matter tracts such as the corpus callosum, the fornix, the corona radiata, anterior and posterior thalamic radiation, the superior and inferior longitudinal fasciculus, the cingulum and the corticospinal tracts ([@bb0220]; [@bb0335], [@bb0340]; [@bb0300], [@bb0305]; [@bb0005]; [@bb0345]), and in deep gray matter structures, including the midbrain, the thalamus, the hippocampus and the caudate nucleus ([@bb0220]; [@bb0325]; [@bb0335]; [@bb0315]; [@bb0305]). Few studies have used tractography to study white matter tracts in PSP ([@bb0005]; [@bb0305]; [@bb0300]). In these analyses, tracts of interest were derived from the probability maps and then diffusion measures were extracted from them. Abnormal FA and MD values were found in PSP patients compared with healthy controls, indicating that white matter damage in these tracts was specific of PSP pathology.

In our study, we used tractography to reconstruct the structural connectome. To our knowledge, this is the first study characterizing white matter abnormalities in PSP through structural connectivity derived from tractography. When studying the brain by only describing its constituent parts, we are missing a key feature: how the different elements of the system (e.g. brain regions) interact. Abnormal interactions between brain regions have been shown to be associated with many neurodegenerative disorders ([@bb0285]). Building the structural connectome allows assessing the disruption effect of neurodegenerative diseases on specific pathways and regions of the network in a way that is closer to our understanding of brain organization ([@bb0125]). In the current work, we observed significant structural connectivity alterations in PSP. Decreased NOS in PSP patients compared with HC were predominantly found in cortico-DGM connections linking frontal areas to the basal ganglia, the ventral diencephalon, the thalamus, the hippocampus and the cerebellum. Abnormal inter and intrahemispheric connections were observed, with a slight predominance in interhemispheric streamlines. No regions showed reductions in structural connectivity in HC compared with PSP patients. These findings were also found when considering only PSP-RS patients.

It is worth noting that the predominant reduction of NOS between frontal and DGM structures was found using a whole-brain approach, with no a priori selection of tracts. This highlights the importance of fronto-DGM pathways disruption in the neuropathological basis and symptomatology of the disease. Furthermore, it relates not only to frontal areas and DGM structures but also to their interaction ([@bb0075]; [@bb0185]; [@bb0070]). The clinical manifestations of PSP are closely linked to defects in this circuitry, including apathy, impulsivity and frontal behavioral disturbances ([@bb0070]; [@bb0035]). Previous studies have observed the relation between frontal disturbances (mostly evaluated with the Frontal Assessment Battery (FAB) or the Frontal Behavioral Inventory (FBI)) and the degeneration of specific white matter tracts and atrophy in subregions of the frontal cortex and DGM structures ([@bb0070]; [@bb0340]; [@bb0005]). Severity of the disease as assessed with the PSPRS scale has also been correlated with white matter abnormalities in PSP-related tracts and structures, such as superior and inferior longitudinal fasciculus, the corpus callosum, the thalamus and the cerebellar peduncles ([@bb0335]; [@bb0005]; [@bb0305]). Our results are in agreement with these findings, as we found correlations between FAB and PSPRS scores and fronto-DGM structural connectivity in PSP patients, which include specific structures in this pathology. As far as we know, the current work is the first study linking changes in structural connectivity assessed through tractography to clinical manifestations in PSP.

Given the volumetric results, it can be hypothesized that the reduced connectivity involving some of these structures and their correlation with clinical features might be explained by their atrophy. Based on these findings, it is difficult to speculate whether the loss of white matter structural connectivity involving DGM regions is secondary to primary gray matter damage and subsequent axonal degeneration, or whether the disease process involves white matter abnormalities directly. However, reduced connectivity between frontal regions and the caudate was also found, along with reduced node degree in the amygdala, both structures not showing volumetric atrophy. Thus, although DGM structures are clearly affected in PSP, structural connectivity can detect changes in regions not presenting detectable atrophy. Furthermore, abnormal FA and MD measures were predominantly observed in the cerebellar peduncles, corpus callosum, bilateral anterior and superior corona radiata, bilateral superior longitudinal fasciculus and bilateral posterior thalamic radiation, in agreement with previous studies ([@bb0220]; [@bb0335], [@bb0340]; [@bb0300], [@bb0305]; [@bb0005]; [@bb0345]). We hypothesized that the connectivity reductions found in this work might be reflecting the loss of integrity in white matter tracts, along with subcortical GM atrophy in PSP patients.

Characterizing the structural connectome through graph theory provides information about the organization of the network ([@bb0125]). When considering the whole brain, a tendency of higher global clustering coefficient, path length and "small-worldness", along with reduced global mean degree could be observed in PSP patients\' networks, although no global metric reached statistical significance. At the nodal level, reductions of nodal degree were found in the hippocampus, the frontal pole and the pars opercularis and triangularis of the inferior frontal gyrus. As previously mentioned, the involvement of frontal areas has been recurrently described in previous studies and it is related with the clinical manifestations of the disease. The hippocampus also seems to play a relevant role in PSP, as it was found to be involved in both reduced connections and abnormal whole-brain graph metrics in PSP patients. Deposits of phosphorylated tau protein is a hallmark of neurodegenerative tauopathies, such as PSP. Although the hippocampus is not primarily affected in this neuropathology, distinctive patterns of tau deposits were observed in previous studies ([@bb0210]), as well as reduced volume in this structure ([@bb0245]; [@bb0330]). We hypothesize that these findings might explain the predominant abnormalities found in the hippocampus in PSP patients.

Given that no major group differences were identified in global measures, possibly due to the regional specificity of the disease-related alterations, we decided to specifically examine the fronto-DGM sub-network, as it seemed to be predominantly affected in PSP. In the fronto-DGM network, PSP patients showed increased local interconnectedness manifested by higher measures of clustering and small-wordness, combined with a reduction of nodal degree, specifically in the bilateral hippocampus, the right amygdala, pallidum, putamen, nucleus accumbens, thalamus, ventral diencephalon and cerebellum, and in cortical areas including the pars opercularis and pars triangularis of the inferior frontal gyrus, the frontal pole, the right precentral gyrus and the left rostral middle frontal gyrus. It is noteworthy that no significant results in global or local graph metrics were found in the other subnetworks. Therefore, these findings suggest that there might be a predominant reorganization of the network comprising frontal and DGM nodes in PSP patients compared with healthy controls.

The small world topology is thought to be a balance between local specialization and global integration when networks evolved from high complexity of dynamic behavior ([@bb0290]). The alteration of the small-world architecture driven by increased clustering coefficient and path length has been reported in different neurological disorders, e.g. Alzheimer\'s disease ([@bb0140]; [@bb0190]; [@bb0350]), Parkinson\'s disease with mild cognitive impairment ([@bb0015]; [@bb0115]) and schizophrenia ([@bb0370]). In agreement with previous connectivity studies, it could be speculated that the increment in local clustering results from short-range connections, whereas the increased path length could imply a reduction of long-range connectivity and consequently a less effective communication within the pathological network in PSP patients. However, it is important to highlight that graph metrics results in neurodegenerative diseases are inconsistent, and that abnormal increases and decreases of small-word topology have been reported. E.g., studies in Alzheimer\'s disease observed decrease of small-word topology in these patients ([@bb0255]; [@bb0295]), contrarily to the increase in small-word properties found in the previously mentioned studies ([@bb0140]; [@bb0190]; [@bb0350]). Some studies have looked into this aspect ([@bb0135]; [@bb0310]), showing that the reproducibility of network metrics can be affected by many factors, e.g., different sample sizes, how connectivity matrices are estimated (deterministic or probabilistic tractography in structural connectivity, full or partial correlation in functional connectivity), using binary or weighted matrices, the number of nodes in the network and the different thresholds applied on the connectivity matrices. These divergences in the methodology, along with different patient characteristics, can contribute to heterogeneous results, complicating the interpretability of graph metrics.

In the last few years, features extracted from different MRI modalities have been introduced into machine learning algorithms to assess their discriminant ability at the single-patient level in parkinsonian syndromes, commonly showing an accuracy around 80%, depending on the disease being evaluated ([@bb0110]; [@bb0100]; [@bb0130], 2013; [@bb0205]; [@bb0215]; [@bb0055]; [@bb0250]; [@bb0155]; [@bb0225]; [@bb0025]). Concretely, two previous studies specifically assessed the classification performance between PSP patients and HC ([@bb0110]; [@bb0250]). Focke and colleagues evaluated features from different modalities (T1, T2 and DTI), achieving a high accuracy of 94% when using diffusion measures from selected subcortical ROIs. Salvatore and colleagues described a whole-brain approach similar to our study. Principal component analysis (PCA) was used to reduce feature dimensionality of T1 images. The relevant features were then introduced into a classifier achieving an accuracy of 88.1%. To our knowledge, our work is the first study assessing the discrimination performance of structural connectivity in atypical parkinsonian patients. In PD patients, a study by Peña-Nogales and colleagues (2019) evaluated the ability of longitudinal structural connectivity to correctly distinguish PD patients from HC, obtaining an accuracy of 83.6%. As it can be shown, our results are in agreement with previous work using structural connectivity data as relevant features to distinguish parkinsonian patients at the single-subject level. It is noteworthy that only one PSP patient with mixed PSP-PGF/PSP-RS features was wrongly classified with the machine learning approach. We hypothesize that connectivity findings presented in this study might not only be linked exclusively to PSP-RS subtype. This idea should be further addressed with a larger sample inspecting possible connectivity differences within subtypes.

Some limitations to the present study should be pointed out. First, the PSP patient sample is relatively small; thus, we cannot assume that the set of structural connections identified in our study would generalize to other datasets. Future multicenter studies should be carried out to replicate our findings. Secondly, we lack confirmation of pathological diagnosis for the patients, which is the only approach that can fully confirm the PSP diagnosis and its subtypes. For this reason, we decided not to consider different PSP subtypes in the main analyses, as we were not able to confirm the subtype diagnosis with post-mortem evaluation. However, the machine learning results seems to indicate that there are no major structural connectivity differences between subtypes within the connections being evaluated in this study. The complementary analysis using only PSP patients with Richardson\'s syndrome showed similar findings. Nevertheless, in order to assess whether these results are mainly driven by the PSP-RS subtype, analyses need to be replicated with a larger sample of patients also encompassing the atypical PSP phenotypes. Thirdly, parcellations and tractography methodologies have a large impact on the characteristics of the reconstructed white matter tracts. Nonetheless, reduced integrity and atrophy of frontal regions and deep gray matter connections have been extensively reported in PSP in previous studies, supporting the validity of the results obtained in our work.

5. Conclusion {#s0115}
=============

In this work, we demonstrated that modelling the brain as a structural connectome is a useful method to detect changes in the organization and topology of white matter tracts in PSP patients. Concretely, we found evidence that structural connectivity between frontal regions and deep gray matter structures is reduced in PSP patients compared with healthy controls and that disease\'s severity and executive dysfunction, measured by PSPRS and FAB scales respectively, are linked to these reductions in fronto-deep gray matter connections in PSP. Additionally, alteration of the small-world architecture implies that the topology of the network is altered, resulting in a less effective communication within the pathological network in PSP patients. Importantly, we showed for the first time that structural connectivity parameters have the potential to help distinguish between PSP patients and healthy controls at the single-subject level with high accuracy.
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[^1]: HC: healthy controls; PSP: Progressive supranuclear palsy patient group; MMSE: Mini-mental state examination; H&Y: Hoehn and Yahr scale; PSPRS: Progressive Supranuclear Palsy Rating Scale; FAB: Frontal Assessment Battery

[^2]: refers to significant results; Stats refers to Student\'s t-test (T) or Pearson\'s chi-square (χ^2^).

[^3]: PSP patients with FAB scale n = 14.

[^4]: HC: healthy controls; PSP: Progressive supranuclear palsy patient group; Stats refers to Student\'s t-test (T).

[^5]: HC: healthy controls; PSP: Progressive supranuclear palsy patient group

[^6]: significant FDR corrected results; Stats refers to Student\'s t-test (T).

[^7]: HC: healthy controls; PSP: Progressive supranuclear palsy patient group; DGM: Deep gray matter structures

[^8]: refers to FDR corrected results; Stats refers to Student\'s t-test (T).

[^9]: HC: healthy controls; PSP: Progressive supranuclear palsy patient group

[^10]: significant FDR corrected results; Stats refers to Student\'s t-test (T).
